Literature DB >> 22760419

Molecular imaging of pediatric brain tumors: comparison of tumor metabolism using ¹⁸F-FDG-PET and MRSI.

Sean J Hipp1, Emilie A Steffen-Smith, Nicholas Patronas, Peter Herscovitch, Jeffrey M Solomon, Robyn S Bent, Seth M Steinberg, Katherine E Warren.   

Abstract

Magnetic resonance spectroscopic imaging (MRSI) and (18)F-fluorodeoxyglucose positron emission tomography (FDG-PET) are non-invasive imaging techniques routinely used to evaluate tumor malignancy in adults with brain tumors. We compared the metabolic activity of pediatric brain tumors using FDG-PET and MRSI. Children (n = 37) diagnosed with a primary brain tumor underwent FDG-PET and MRSI within two weeks of each other. Tumor metabolism was classified as inactive, active or highly active using the maximum choline:N-acetyl-asparate (Cho:NAA) on MRSI and the highest tumor uptake on FDG-PET. A voxel-wise comparison was used to evaluate the area with the greatest abnormal metabolism. Agreement between methods was assessed using the percent agreement and the kappa statistic (κ). Pediatric brain tumors were metabolically heterogeneous on FDG-PET and MRSI studies. Active tumor metabolism was observed more frequently using MRSI compared to FDG-PET, and agreement in tumor classification was weak (κ = 0.16, p = 0.12), with 42 % agreement (95 % CI = 25-61 %). Voxel-wise comparison for identifying the area of greatest metabolic activity showed overlap in the majority (62 %) of studies, though exact agreement between techniques was low (29.4 %, 95 % CI = 15.1-47.5 %). These results indicate that FDG-PET and MRSI detect similar but not always identical regions of tumor activity, and there is little agreement in the degree of tumor metabolic activity between the two techniques.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22760419      PMCID: PMC3482688          DOI: 10.1007/s11060-012-0918-0

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  29 in total

1.  A global optimisation method for robust affine registration of brain images.

Authors:  M Jenkinson; S Smith
Journal:  Med Image Anal       Date:  2001-06       Impact factor: 8.545

2.  Prediction of pathology and survival by FDG PET in gliomas.

Authors:  M V Padma; S Said; M Jacobs; D R Hwang; K Dunigan; M Satter; B Christian; J Ruppert; T Bernstein; G Kraus; J C Mantil
Journal:  J Neurooncol       Date:  2003-09       Impact factor: 4.130

3.  Predicting outcome of children with diffuse intrinsic pontine gliomas using multiparametric imaging.

Authors:  Sean J Hipp; Emilie Steffen-Smith; Dima Hammoud; Joanna H Shih; Robyn Bent; Katherine E Warren
Journal:  Neuro Oncol       Date:  2011-07-13       Impact factor: 12.300

4.  In vivo proton magnetic resonance spectroscopic signal processing for the absolute quantitation of brain metabolites.

Authors:  Pravat K Mandal
Journal:  Eur J Radiol       Date:  2011-04-22       Impact factor: 3.528

5.  Proton magnetic resonance spectroscopy predicts survival in children with diffuse intrinsic pontine glioma.

Authors:  Emilie A Steffen-Smith; Joanna H Shih; Sean J Hipp; Robyn Bent; Katherine E Warren
Journal:  J Neurooncol       Date:  2011-05-13       Impact factor: 4.130

6.  Evaluation of 18F-FDG PET and MRI associations in pediatric diffuse intrinsic brain stem glioma: a report from the Pediatric Brain Tumor Consortium.

Authors:  Katherine A Zukotynski; Frederic H Fahey; Mehmet Kocak; Abass Alavi; Terence Z Wong; S Ted Treves; Barry L Shulkin; Daphne A Haas-Kogan; Jeffrey R Geyer; Sridhar Vajapeyam; James M Boyett; Larry E Kun; Tina Young Poussaint
Journal:  J Nucl Med       Date:  2011-01-13       Impact factor: 10.057

7.  Comparison of proton magnetic resonance spectroscopy with fluorine-18 2-fluoro-deoxyglucose positron emission tomography for assessment of brain tumor progression.

Authors:  Farzin Imani; Fernando E Boada; Frank S Lieberman; Denise K Davis; Erin L Deeb; James M Mountz
Journal:  J Neuroimaging       Date:  2010-12-14       Impact factor: 2.486

Review 8.  Childhood brain tumors: epidemiology, current management and future directions.

Authors:  Ian F Pollack; Regina I Jakacki
Journal:  Nat Rev Neurol       Date:  2011-07-26       Impact factor: 42.937

9.  Proton magnetic resonance spectroscopic imaging in children with recurrent primary brain tumors.

Authors:  K E Warren; J A Frank; J L Black; R S Hill; J H Duyn; A A Aikin; B K Lewis; P C Adamson; F M Balis
Journal:  J Clin Oncol       Date:  2000-03       Impact factor: 44.544

10.  Metabolic characterization of childhood brain tumors: comparison of 18F-fluorodeoxyglucose and 11C-methionine positron emission tomography.

Authors:  Meri Utriainen; Liisa Metsähonkala; Toivo T Salmi; Tapio Utriainen; Hannu Kalimo; Helena Pihko; Anne Mäkipernaa; Arja Harila-Saari; Sirkku Jyrkkiö; Jukka Laine; Kjell Någren; Heikki Minn
Journal:  Cancer       Date:  2002-09-15       Impact factor: 6.860

View more
  10 in total

1.  Grading and outcome prediction of pediatric diffuse astrocytic tumors with diffusion and arterial spin labeling perfusion MRI in comparison with 18F-DOPA PET.

Authors:  Giovanni Morana; Arnoldo Piccardo; Domenico Tortora; Matteo Puntoni; Mariasavina Severino; Paolo Nozza; Marcello Ravegnani; Alessandro Consales; Samantha Mascelli; Alessandro Raso; Manlio Cabria; Antonio Verrico; Claudia Milanaccio; Andrea Rossi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-07-27       Impact factor: 9.236

Review 2.  Emerging applications of metabolomics in drug discovery and precision medicine.

Authors:  David S Wishart
Journal:  Nat Rev Drug Discov       Date:  2016-03-11       Impact factor: 84.694

3.  Advanced MR imaging and 18F-DOPA PET characteristics of H3K27M-mutant and wild-type pediatric diffuse midline gliomas.

Authors:  Arnoldo Piccardo; Domenico Tortora; Samantha Mascelli; Mariasavina Severino; Gianluca Piatelli; Alessandro Consales; Marco Pescetto; Veronica Biassoni; Elisabetta Schiavello; Michela Massollo; Antonio Verrico; Claudia Milanaccio; Maria Luisa Garrè; Andrea Rossi; Giovanni Morana
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-04-27       Impact factor: 9.236

4.  Diagnostic and prognostic value of 18F-DOPA PET and 1H-MR spectroscopy in pediatric supratentorial infiltrative gliomas: a comparative study.

Authors:  Giovanni Morana; Arnoldo Piccardo; Matteo Puntoni; Paolo Nozza; Armando Cama; Alessandro Raso; Samantha Mascelli; Michela Massollo; Claudia Milanaccio; Maria Luisa Garrè; Andrea Rossi
Journal:  Neuro Oncol       Date:  2015-09-23       Impact factor: 12.300

Review 5.  PET and SPECT studies in children with hemispheric low-grade gliomas.

Authors:  Csaba Juhász; Edit Bosnyák
Journal:  Childs Nerv Syst       Date:  2016-09-20       Impact factor: 1.475

Review 6.  Metabolomics Applications in Precision Medicine: An Oncological Perspective.

Authors:  Leonor Puchades-Carrasco; Antonio Pineda-Lucena
Journal:  Curr Top Med Chem       Date:  2017       Impact factor: 3.295

7.  Application of siemens SMART neuro attenuation correction in brain PET imaging.

Authors:  Xiaonan Shao; Mei Xu; Chun Qiu; Rong Niu; Yuetao Wang; Xiaosong Wang
Journal:  Medicine (Baltimore)       Date:  2018-09       Impact factor: 1.817

Review 8.  Metabolomics Contributions to the Discovery of Prostate Cancer Biomarkers.

Authors:  Nuria Gómez-Cebrián; Ayelén Rojas-Benedicto; Arturo Albors-Vaquer; José Antonio López-Guerrero; Antonio Pineda-Lucena; Leonor Puchades-Carrasco
Journal:  Metabolites       Date:  2019-03-08

9.  Apatinib induces 3-hydroxybutyric acid production in the liver of mice by peroxisome proliferator-activated receptor α activation to aid its antitumor effect.

Authors:  Siqi Feng; Huan Wang; Ying Wang; Runbin Sun; Yuan Xie; Zhu Zhou; Hong Wang; Jiye Aa; Fang Zhou; Guangji Wang
Journal:  Cancer Sci       Date:  2019-09-05       Impact factor: 6.716

10.  Joint EANM/SIOPE/RAPNO practice guidelines/SNMMI procedure standards for imaging of paediatric gliomas using PET with radiolabelled amino acids and [18F]FDG: version 1.0.

Authors:  Arnoldo Piccardo; Nathalie L Albert; Lise Borgwardt; Frederic H Fahey; Darren Hargrave; Norbert Galldiks; Nina Jehanno; Lars Kurch; Ian Law; Ruth Lim; Egesta Lopci; Lisbeth Marner; Giovanni Morana; Tina Young Poussaint; Victor J Seghers; Barry L Shulkin; Katherine E Warren; Tatjana Traub-Weidinger; Pietro Zucchetta
Journal:  Eur J Nucl Med Mol Imaging       Date:  2022-05-10       Impact factor: 10.057

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.